Aslani, Iris .
HRN: 24-25-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2024
AMPICILLIN 500MG (VIAL)
05/13/2024
05/20/2024
IV
138
Q6
PCAP, T/C CNS INFECTION
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes